151 related articles for article (PubMed ID: 29965993)
1. SYNTAX score II predicts long-term mortality in patients with one- or two-vessel disease.
Vroegindewey MM; Schuurman AS; Oemrawsingh RM; van Geuns RJ; Kardys I; Ligthart J; Daemen J; Boersma E; Serruys PW; Akkerhuis KM
PLoS One; 2018; 13(7):e0200076. PubMed ID: 29965993
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial.
Campos CM; Stanetic BM; Farooq V; Walsh S; Ishibashi Y; Onuma Y; Garcia-Garcia HM; Escaned J; Banning A; Serruys PW;
Catheter Cardiovasc Interv; 2015 Nov; 86(6):E229-38. PubMed ID: 25946686
[TBL] [Abstract][Full Text] [Related]
3. Assessment of long-term mortality in patients with complex coronary artery disease undergoing percutaneous intervention: comparison of multiple anatomical and clinical prognostic risk scores.
Janella BL; Campos CM; Caixeta A; Almeida BO; Brito FS; Abizaid A; Perin MA
EuroIntervention; 2017 Nov; 13(10):1177-1184. PubMed ID: 28506936
[TBL] [Abstract][Full Text] [Related]
4. Association of serum uric acid levels with SYNTAX score II and long term mortality in the patients with stable angina pectoris who undergo percutaneous coronary interventions due to multivessel and/or unprotected left main disease.
Karabağ Y; Rencuzogullari I; Çağdaş M; Karakoyun S; Yesin M; Atalay E; Çağdaş ÖS; Gürsoy MO; Burak C; Tanboğa HI
Int J Cardiovasc Imaging; 2019 Jan; 35(1):1-7. PubMed ID: 30143922
[TBL] [Abstract][Full Text] [Related]
5. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
[TBL] [Abstract][Full Text] [Related]
6. Impact of non-respect of SYNTAX score II recommendation for surgery in patients with left main coronary artery disease treated by percutaneous coronary intervention: an EXCEL substudy.
Modolo R; Chichareon P; van Klaveren D; Dressler O; Zhang Y; Sabik JF; Onuma Y; Kappetein AP; Stone GW; Serruys PW
Eur J Cardiothorac Surg; 2020 Apr; 57(4):676-683. PubMed ID: 31620778
[TBL] [Abstract][Full Text] [Related]
7. Predictive Performance of SYNTAX Score II in Patients With Left Main and Multivessel Coronary Artery Disease-analysis of CREDO-Kyoto registry.
Campos CM; van Klaveren D; Iqbal J; Onuma Y; Zhang YJ; Garcia-Garcia HM; Morel MA; Farooq V; Shiomi H; Furukawa Y; Nakagawa Y; Kadota K; Lemos PA; Kimura T; Steyerberg EW; Serruys PW
Circ J; 2014; 78(8):1942-9. PubMed ID: 24998278
[TBL] [Abstract][Full Text] [Related]
8. Comparison of multiple risk scores in assessing medium-to long-term clinical outcomes in unstable angina / non-ST-elevation myocardial infarction patients undergoing multi vessel percutaneous coronary intervention: An observational, registry-based study in India.
Sebastian G; Pillai V; Manzil A; Damodara R; Kalra I; Abdul Z; Mathew O
Indian Heart J; 2021; 73(5):555-560. PubMed ID: 34627568
[TBL] [Abstract][Full Text] [Related]
9. ApPropriateness of myocaRdial RevascularizatiOn assessed by the SYNTAX score II in a coUntry without cardiac Surgery faciliTies; PROUST study.
Stanetic BM; Ostojic M; Campos CM; Marinkovic J; Farooq V; Kovacevic-Preradovic T; Huber K; Serruys PW
Int J Cardiol; 2017 Jan; 227():478-484. PubMed ID: 27825727
[TBL] [Abstract][Full Text] [Related]
10. External validation of the SYNTAX score II 2020 in patients with chronic renal insufficiency.
Li M; Liu X; Jiang M; Lei Y; Liu W; Li Z; Li S; Liu R; Cao X; Yan L
Catheter Cardiovasc Interv; 2024 Feb; 103(3):391-403. PubMed ID: 38204355
[TBL] [Abstract][Full Text] [Related]
11. Validation and comparison of the long-term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention.
Xu B; Généreux P; Yang Y; Leon MB; Xu L; Qiao S; Wu Y; Yan H; Chen J; Zhao Y; Zhao Y; Palmerini T; Stone GW; Gao R
JACC Cardiovasc Interv; 2014 Oct; 7(10):1128-37. PubMed ID: 25240551
[TBL] [Abstract][Full Text] [Related]
12. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.
Campos CM; van Klaveren D; Farooq V; Simonton CA; Kappetein AP; Sabik JF; Steyerberg EW; Stone GW; Serruys PW;
Eur Heart J; 2015 May; 36(20):1231-41. PubMed ID: 25583761
[TBL] [Abstract][Full Text] [Related]
13. SYNTAX Score-II Predicts Long-Term Mortality in Patients Who Underwent Left Main Percutaneous Coronary Intervention Treated With Second-Generation Drug-Eluting Stents.
He J; Zhao H; Yu X; Li Q; Lv S; Chen F; Jiang T
Int Heart J; 2017 May; 58(3):344-350. PubMed ID: 28539567
[TBL] [Abstract][Full Text] [Related]
14. Coronary atherosclerotic burden assessed by SYNTAX scores and outcomes in surgical, percutaneous or medical strategies: a retrospective cohort study.
Scudeler TL; Farkouh ME; Hueb W; Rezende PC; Campolina AG; Martins EB; Godoy LC; Soares PR; Ramires JAF; Kalil Filho R
BMJ Open; 2022 Sep; 12(9):e062378. PubMed ID: 36137633
[TBL] [Abstract][Full Text] [Related]
15. SYNTAX score II in patients with coronary artery disease undergoing percutaneous mitral repair with the MitraClip.
Obeid S; Attinger-Toller A; Taramasso M; Pedrazzini G; Suetsch G; Landolt F; Karbeyaz F; Rodriguez H; Sürder D; Moccetti T; Nietlispach F; Maisano F
Int J Cardiol; 2017 Jun; 236():375-380. PubMed ID: 28283362
[TBL] [Abstract][Full Text] [Related]
16. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.
Capodanno D; Caggegi A; Miano M; Cincotta G; Dipasqua F; Giacchi G; Capranzano P; Ussia G; Di Salvo ME; La Manna A; Tamburino C
JACC Cardiovasc Interv; 2011 Mar; 4(3):287-97. PubMed ID: 21435606
[TBL] [Abstract][Full Text] [Related]
17. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
[TBL] [Abstract][Full Text] [Related]
18. Role of euroSCORE II in predicting long-term outcome after percutaneous catheter intervention for coronary triple vessel disease or left main stenosis.
Zhao M; Stampf S; Valina C; Kienzle RP; Ferenc M; Gick M; Essang E; Nührenberg T; Büttner HJ; Schumacher M; Neumann FJ
Int J Cardiol; 2013 Oct; 168(4):3273-9. PubMed ID: 23664045
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Predictive Value of SYNTAX-II Score for Adverse Cardiac Events and Clinical Outcomes in Patients With Acute Coronary Syndrome.
Yuksel Y; Yildiz C; Kose S
Angiology; 2023 Jun; ():33197231181958. PubMed ID: 37295413
[TBL] [Abstract][Full Text] [Related]
20. Complexity of coronary artery disease affects outcome of patients undergoing coronary artery bypass grafting with impaired left ventricular function.
Melina G; Angeloni E; Benedetto U; Monti F; Roscitano A; Serdoz R; Sinatra R
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):656-61. PubMed ID: 22995728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
